Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Author
Find an Article (54983030)
Find a Category (126)
Find a Journal (6151)
Find a Scholar (4058)
Find an Academic Assistant (17)
Find an Article PDF (4588750)
Today's Articles (18)
Subscriber (49292)
Download
Citation(s) in
RCA
1
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2014 (1)
Show more
Refine
Article Type
Show more
Refine
Article Statistics
ESCI (1)
RCA (1)
Refine
MESH Headings
Show more
Refine
First Author
Florian Huemer (1)
Show more
Refine
Authors
Florian Huemer (1)
Michael Gnant (1)
Rupert Bartsch (1)
Show more
Refine
Publication Titles
CURRENT BREAST CANCER REPORTS (1)
Show more
Refine
Grant Agencies
Show more
Refine
Countries/Regions
Show more
Refine
Affiliations
Show more
Refine
Category
Oncology (1)
Show more
Refine
For:
Gonzalez-Angulo AM
, Krop I, Piha-Paul S, Li Y, Culotta KS, Moulder-Thompson S, Tsimberidou A, Velez-Bravo VM, Madden TL, Norberg LM, Doyle A, Winder EP, Mills GB, Meric-Bernstam F, Kurzrock R.
Abstract LB-231: Phase Ib dose escalation and biomarker study of MK2206 in combination with standard doses of weekly paclitaxel in patients with locally advanced or metastatic solid tumors with expansion in advanced breast cancer.
Clin Trials
2014. [DOI:
10.1158/1538-7445.am2012-lb-231
]
[
Citation(s) in
RCA
: 1
]
[
Impact Index Per Article: 0.1
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/16/2022]
Number
Cited by Other Article(s)
1
Huemer F
, Bartsch R, Gnant M.
The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer.
Curr Breast Cancer Rep
2014. [DOI:
10.1007/s12609-014-0139-y
]
[
Citation(s) in
RCA
: 6
]
[
Impact Index Per Article: 0.6
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/24/2022]
Abstract
Collapse
Key Words
Collapse
MESH Headings
Collapse
Grants
Collapse
Affiliation(s)
Collapse
Page 1 of 1
1
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…